GloPID-R is a unique international network of major research funding organizations.
Together, we facilitate a rapid and effective response to infectious disease outbreaks.
Our Work
Our aim is to invest in research capacity and capabilities to support the rapid initiation of scientific research in case of an outbreak.
Clinical Trial
Networks
Hear from the experts on topics such as social science, data sharing, capacity building, and EARL barriers.
Read more29 members
Since its creation in 2013, GloPID-R has steadily increased its membership. Today, it consists of 29 members worldwide. The World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) are also actively engaged in the network.
All membersLatest news
All newsGlobal COVID-19 research agenda still missing the priorities of low- and middle-income countries
07/05/2021An article published today in The Lancet calls for urgent collaboration and coordination for unmet, underfunded COVID-19 research priorities in low-resource settings. Over...
Read moreFunding opportunity: Four calls for research on coronavirus variants with €123 million earmarked for research and innovation
13/04/2021To address the growing threat of coronavirus variants, the European Commission has launched four calls for research to complement earlier...
Read moreGloPID-R observer CEPI launches funding call to develop broadly protective coronavirus vaccines
09/04/2021With the emergence of novel SARS-CoV-2 variants and the threat of future coronavirus outbreaks, GLOPID-R observer the Coalition for Epidemic...
Read moreResources
GloPID-R publishes funding opportunities related to infectious diseases and shares its expertise through its publications and webinars.
All resources